Navigation Links
Notre Dame scientists develop largest developmental proteomic data set for any animal
Date:3/27/2014

l time; fate maps for organ development have been determined and major regulators of these processes have been identified and characterized, providing an abundance of tissue- and organ-specific markers to track embryo formation. Additionally, embryos develop rapidly, achieving a nearly fully developed nervous system within four days. "It's easy to manipulate the embryos to mimic certain disease states, making Xenopus extremely valuable to biologists," Huber said.

"The collaborative, ground-breaking work of Norm Dovichi, Paul Huber and their team is crucial to helping us understand the complexity of life. We are proud of this important milestone," said Greg Crawford, dean of the College of Science at the University of Notre Dame.


'/>"/>

Contact: Norm Dovichi
ndovichi@nd.edu
574-631-2778
University of Notre Dame
Source:Eurekalert

Page: 1 2

Related biology news :

1. Notre Dame chemists discover new class of antibiotics
2. Notre Dame paper sheds light on genetic and physiological basis for metabolic diseases
3. Notre Dame researchers develop system that uses a big data approach to personalized healthcare
4. Notre Dame study finds Asian carp DNA not widespread in the Great Lakes
5. Notre Dame researcher is studying role small dams play in pollution control
6. Notre Dame researchers are using new technologies to combat invasive species
7. Notre Dame research may have important implications for combating diabetes
8. Cargill expands support of Notre Dame Haiti Program
9. Notre Dame research reveals migrating Great Lakes salmon carry contaminants upstream
10. Notre Dame research could improve sustainability and cost effectiveness of wastewater treatment
11. Notre Dame research could provide new insights into tuberculosis and other diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... 2014 Sandata Technologies, LLC, an industry ... care, today announced it released a case study ... Visit Verification™ Solution (EVV™)  for Quality Care Services, ... company founded in 1996 and has five locations ... The study details the challenges facing Quality ...
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
(Date:10/15/2014)... Oct. 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market releases photos and video ... Square on Monday October 13 th . ... Tunnel and angel investor Mr. Chad A. Verdi ... of NXT-ID thanked his investors and employees "for their work and ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
... . . Families of thousands of victims ... receive appropriate punishment, because of a suite of technologies ... some graves, perhaps hundreds of thousands remain undiscovered. Researchers ... Oak Ridge National Laboratory are developing a method to ...
... organs in the body has shown to provide effective treatment ... Bristol researchers and published in Nature Communications , could ... carotid body a small nodule (no larger than a ... appears to be a major culprit in the development ...
... with a complex heart condition called hypertrophic cardiomyopathy (HCM) found ... for heart transplantation was greatest for those who developed this ... who also had selective inborn errors of metabolism, a group ... the body,s key metabolic processes are disrupted. The ...
Cached Biology News:September 2013 story tips 2September 2013 story tips 3Size really does not matter when it comes to high blood pressure 2Risk factors help predict outcomes for children with rare heart condition 2
(Date:10/20/2014)... 20, 2014 The report “Pharmacy ... Systems, Packaging and Labeling Systems, Table-top Counters) by ... Global Forecasts & Trends to 2019” analyzes and ... in North America, Europe, Asia-Pacific, and the Rest ... tables and 30 figures spread through 300 pages ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Partners LLC, announced today that Ellen Teplitzky, an ... support for the pharmaceutical industry, has joined the ... of its legal services practice. NDA Partners ... expert witness and testimony, to top law firms ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... and Automation as well as Immunoassay ... and Infectious ... Medical Solutions,Diagnostics, (http://www.siemens.com/diagnostics ), announced today that it ... ), a,Group Purchasing Organization (GPO) and supply chain management ...
... 4 /PRNewswire-FirstCall/ - Ms. Mary Ann Dillahunty, Vice,President, Intellectual ... present a corporate overview of the Company at BIO,InvestorForum ... The conference,will be held at the Palace Hotel in ... audio link to the webcast presentation is available on ...
... CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RVX) ... is,making an oral presentation of key scientific data ... International Symposium for Drugs Affecting,Lipid Metabolism (DALM). The ... A-l and HDL cholesterol", will be presented by,Dr. ...
Cached Biology Technology:MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions 2MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions 3Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007 2Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM 2